Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is ‘unique’. Located in Lake Tahoe, Nevada, PDL is a publicly traded private equity group listed on Nasdaq: #PDLI.
‘PDL allows investors to derisk and invest in a portfolio of products and companies’ says Mr Garcia. ‘We recently bought a company and bought a drug to put into that company. We don’t do research and development ourselves. We acquire income streams’.
PDL BioPharma seeks to provide a significant return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries.
This interview is one of a series with Edison pharma clients shot at the Biotech and Money Conference at the Waldorf Hotel, London on 14.11.2017.